Peptidylargenine deaminase 2 (PAD2) is an enzyme responsible for the citrullination of GFAP and the amount of PAD2 and citrullinated GFAP is increased in the hippocampi of AD patients compared to non‐AD controls (Ishigami et al., 2015). This evidence concerns the gene PADI2 and Alzheimer disease.